Advanced Accelerator Applications

This page shows the latest Advanced Accelerator Applications news and features for those working in and with pharma, biotech and healthcare.

Novartis buys cancer specialist Endocyte for $2.1bn

177. Lu- oxodotreotide) for gastroenteropancreatic neuroendocrine (GEP-NET) tumours, acquired along with French company Advanced Accelerator Applications for $3.9bn a year ago.

Latest news

Novartis follows Pfizer and freezes US prices this year

ploughing the cash back into the pipeline-enriching acquisitions of gene therapy company AveXis and radiopharma specialist Advanced Accelerator Applications – and going ahead with the spin-off its Alcon eyecare unit.
AAA board presses go on $3.9bn Novartis takeover

Novartis has started its cash tender offer for French firm Advanced Accelerator Applications, which specialises in radiopharmaceuticals to treat cancer.
Novartis to buy French radiopharma specialist AAA for $3.9bn

Novartis has agreed a $3.9bn deal to buy Advanced Accelerator Applications, a French company specialising in nuclear medicines used to treat tumours. ... The transaction gives Novartis “both near-term product launches as well as a new technology
AAA’s orphan drug Lutathera wins EU green light

Advanced Accelerator Applications’ (AAA) Lutathera (lutetium oxodotreotide) has received European approval to treat adults with unresectable or metastatic, somatostatin receptor positive gastroenteropancreatic neuroendocrine tumours.
CHMP backs three immuno-oncology drugs for solid tumours

Advanced Accelerator Applications secured a recommendation for Lutathera (lutetium [177Lu] oxodotreotide) - for the treatment of gastro-entero-pancreatic neuroendocrine tumours - and Ipsen got the nod for Xermelo (telotristat ethyl) as a

More from news
Approximately 2 fully matching, plus 4 partially matching documents found.

Latest appointments

Abeona Therapeutics appoints new additions to board of directors

Buono was previously the chief executive officer and president of Advanced Accelerator Applications, an international radiopharmaceutical company he founded in 2002.
Former Roche development head joins Asana advisory board

The founder of KAPital Consulting, Dr Dhingra currently serves on the boards of Exosome Diagnostics as chairman of the board, Advanced Accelerator Applications, Five Prime and Autolus.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Senior Account Manager: Competitive Salary Offered

Senior Editorial Assistant – Greater Manchester: DOE

Senior Developer with management potential, Healthcare Brand Com...: circa £50K

Principal Health Economist - North-West: Negotiable

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Account Manager- Healthcare Advertising: Negotiable

Account Director: Competitive Salary Offered

Experienced Medical Writers: Competitive Salary and Benefits

Account Manager / Account Director: Competative

Senior Account Manager- Central Oxford and Abingdon: Negotiable

Account Executive/ Senior Account Executive: competitive Salary Offfered

Account Manager – Creative Healthcare Advertising – Central Lond...: Salary TBC

Healthcare Advertising Senior Account Manager / AD / Senior AD: Salary TBC

Account Director - Healthcare Advertising - London - HOME WORKIN...: £50000 - £68000

Business Director: Competitive Salary Offered

Editorial Manager - MedComms: DOE

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Healthcare Communications Account Directors x 2: Salary TBC

Digital Communications Lead, Healthcare Brand and Medical Commun...: up to £50K

Account Manager / Senior Account Manager: 35, 000-40, 000

Medical (Scientific) Director: £120, 000 benefits

Account Manager- Healthcare Advertising: Negotiable

Account Director – Healthcare Marketing – Berks: Salary TBC

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Senior Account Executive with progression to Account Manager, Me...: Excellent package

Subscribe to our email news alerts

PMHub

Add my company

Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?: What do you think is the difference between a campaign developed to win a share-of-mind with consumers and a campaign designed to gain the attention of healthcare professionals?...
What everyone forgets about good organisational change in pharma: Natasha Cowan speaks to Daphne Chung, Head of Organisational Transformation, to learn how she ensures smooth organisational change that takes all stakeholders into account....
Live from Singapore: Oncology in APAC - Evaluating the opportunity for novel therapies: Live webinar: Tuesday 11th December 2018,16:00 SGT / 17:00 JST...